Rangaswamy Govindarajan, M.D., hematologist and oncologist at the University of Arkansas for Medical Sciences, has been appointed chief of the Division of Hematology and Oncology at the UAMS Winthrop P. Rockefeller Cancer Institute.
Govindarajan, who is also a professor in the division, will lead a growing team of physicians treating patients with benign and malignant hematological disorders, multiple myeloma, and solid tumors. He will help the faculty develop investigator initiated clinical trials, including translational research.
The UAMS Hematology and Oncology Division, part of the Department of Internal Medicine in the College of Medicine, includes the state’s only stem cell, bone marrow transplant, and cellular therapy program.
“Dr. Govindarajan is the ideal person for this key leadership role at a dynamic time as we introduce cutting edge new treatments, expand our care teams, create a cancer network with Baptist Health and pursue NCI designation,” said Michael Birrer, director of the Winthrop P. Rockefeller Cancer Institute and UAMS vice chancellor.
Govindarjan joined UAMS in 1998 after completing medical training at UAMS, including a residency in internal medicine and a fellowship in hematology and oncology. He is board-certified in internal medicine and hematology and oncology, and a diplomate of the American Board of Internal Medicine and the National Board of Internal Medicine.
Govindarajan received a medical degree from Mysore Medical College, University of Mysore in Mysore, India. He is also a member of the Royal College of physicians, United Kingdom.